{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:00:27Z","timestamp":1791406827704,"version":"4.3.3"},"reference-count":148,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T00:00:00Z","timestamp":1557705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jhepr.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T17:38:14Z","timestamp":1564594694000},"page":"214-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"title":["The role of the gut microbiome in chronic liver disease: the clinical evidence revised"],"prefix":"10.1016","volume":"1","author":[{"given":"Katherine JP","family":"Schwenger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayima","family":"Clermont-Dejean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johane P.","family":"Allard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2019.04.004_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40168-015-0094-5","article-title":"The vocabulary of microbiome research: a proposal","volume":"3","author":"Marchesi","year":"2015","journal-title":"Microbiome"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0010","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1113\/jphysiol.2009.174136","article-title":"The core gut microbiome, energy balance and obesity","volume":"587","author":"Turnbaugh","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0015","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1124234","article-title":"Metagenomic analysis of the human distal gut microbiome","volume":"312","author":"Gill","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/2050640613502477","article-title":"Hot topics in gut microbiota","volume":"1","author":"Dore","year":"2013","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/510385","article-title":"The role of microbes in Crohn's disease","volume":"44","author":"Eckburg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1469-0691.2012.03865.x","article-title":"Metagenomics of human microbiome: beyond 16s rDNA","volume":"18","author":"Gosalbes","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0040","doi-asserted-by":"crossref","first-page":"751S","DOI":"10.1093\/jn\/137.3.751S","article-title":"Metabolic diversity of the intestinal microbiota: implications for health and disease","volume":"137","author":"Blaut","year":"2007","journal-title":"J Nutr"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","article-title":"Intestinal microbiota in functional bowel disorders: a Rome foundation report","volume":"62","author":"Simren","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms4020020","article-title":"Microbiome, Metabolome and Inflammatory Bowel Disease","volume":"4","author":"Ahmed","year":"2016","journal-title":"Microorganisms"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0055","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2174\/138161209788168164","article-title":"The role of the gut microbiota in energy metabolism and metabolic disease","volume":"15","author":"Cani","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cld.2013.09.002","article-title":"Obesity and NAFLD: The role of bacteria and microbiota","volume":"18","author":"Duseja","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-410524-9.00003-7","article-title":"The intestinal microbiota in chronic liver disease","volume":"117","author":"Henao-Mejia","year":"2013","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","article-title":"Interaction of gut microbiota with bile acid metabolism and its influence on disease states","volume":"101","author":"Staley","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","volume":"56","author":"Long","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0085","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0090","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","article-title":"Bile acids as regulatory molecules","volume":"50","author":"Hylemon","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2015.12.007","article-title":"Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules","volume":"104","author":"Copple","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gutjnl-2015-310283","article-title":"Microbiota-induced obesity requires farnesoid X receptor","volume":"66","author":"Parseus","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2009.05.038","article-title":"Intestinal barrier function: molecular regulation and disease pathogenesis","volume":"124","author":"Groschwitz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajpath.2012.10.014","article-title":"Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14","volume":"182","author":"Guo","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0125","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate Immunity and Inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/1469-0691.12140","article-title":"Gut microbiota and non-alcoholic fatty liver disease: new insights","volume":"19","author":"Aron-Wisnewsky","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0140","doi-asserted-by":"crossref","first-page":"19867","DOI":"10.3390\/ijms141019867","article-title":"Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis","volume":"14","author":"Vonghia","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0150","doi-asserted-by":"crossref","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","article-title":"Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production","volume":"287","author":"Tosello-Trampont","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0155","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1038\/srep07259","article-title":"Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota","volume":"4","author":"Chen","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/imm.12180","article-title":"Probiotic antigens stimulate hepatic natural killer T cells","volume":"141","author":"Liang","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0165","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/hep.26115","article-title":"Natural killer cells in liver disease","volume":"57","author":"Tian","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0170","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1111\/j.1440-1746.2007.05274.x","article-title":"Innate immunity and alcoholic liver fibrosis","volume":"23","author":"Jeong","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what's in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2036.2007.03562.x","article-title":"Review article: the role of butyrate on colonic function","volume":"27","author":"Hamer","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.33549\/physiolres.931271","article-title":"Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon","volume":"58","author":"Gaudier","year":"2009","journal-title":"Physiol Res"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0190","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/gut.52.10.1442","article-title":"Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts","volume":"52","author":"Willemsen","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0195","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1038\/sj.onc.1206521","article-title":"Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation","volume":"22","author":"Augenlicht","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0200","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","article-title":"Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription","volume":"57","author":"Wang","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0205","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","article-title":"Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells","volume":"12","author":"Pant","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0210","article-title":"Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0215","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0006-291X(02)00294-2","article-title":"Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation","volume":"293","author":"Kinoshita","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","article-title":"Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression","volume":"28","author":"Corbin","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0225","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1753-4887.2009.00246.x","article-title":"Choline: an essential nutrient for public health","volume":"67","author":"Zeisel","year":"2009","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0230","doi-asserted-by":"crossref","first-page":"21307","DOI":"10.1073\/pnas.1215689109","article-title":"Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme","volume":"109","author":"Craciun","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0240","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/nm.2895","article-title":"A complex microworld in the gut: gut microbiota and cardiovascular disease connectivity","volume":"18","author":"Howitt","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.M051680","article-title":"Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis","volume":"56","author":"Shih","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0250","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0255","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3945\/an.114.007955","article-title":"Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes","volume":"7","author":"Sherriff","year":"2016","journal-title":"Adv Nutr"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0260","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","article-title":"Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency","volume":"140","author":"Spencer","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0265","first-page":"G951","article-title":"Use of measurements of ethanol absorption from stomach and intestine to assess human ethanol metabolism","volume":"273","author":"Levitt","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0270","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/gast.2000.19267","article-title":"Increased gastrointestinal ethanol production in obese mice: Implications for fatty liver disease pathogenesis","volume":"119","author":"Cope","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0006-3002(56)90148-2","article-title":"The formation of ethanol in Escherichia coli","volume":"22","author":"Dawes","year":"1956","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0280","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jnutbio.2015.08.012","article-title":"Glutamine supplementation attenuates ethanol-induced disruption of apical junctional complexes in colonic epithelium and ameliorates gut barrier dysfunction and fatty liver in mice","volume":"27","author":"Chaudhry","year":"2016","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-59745-242-7_13","article-title":"Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer","volume":"447","author":"Rao","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0290","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0891-5849(01)00757-2","article-title":"Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease","volume":"32","author":"Mottaran","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0295","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/1751-2980.12375","article-title":"Alcoholic liver disease: focus on prodromal gut health","volume":"17","author":"Park","year":"2016","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0300","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","article-title":"Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target","volume":"7","author":"Wang","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0305","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.24018","article-title":"Enteric dysbiosis associated with a mouse model of alcoholic liver disease","volume":"53","author":"Yan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0310","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s11892-002-0085-3","article-title":"Hepatic steatosis and type 2 diabetes mellitus","volume":"2","author":"Clark","year":"2002","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0320","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0325","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0330","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc06-2247","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0335","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0340","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","article-title":"Faecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease","volume":"11","author":"Raman","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0345","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0350","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0355","article-title":"Molecular characterization of the faecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study","volume":"8","author":"Wong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0360","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0365","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41598-018-19753-9","article-title":"Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance","volume":"8","author":"Da Silva","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0370","first-page":"2229","article-title":"Markers of activated inflammatory cells are associated with disease severity and intestinal microbiota in adults with nonalcoholic fatty liver disease","volume":"42","author":"Schwenger","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0375","doi-asserted-by":"crossref","first-page":"G881","DOI":"10.1152\/ajpgi.00006.2004","article-title":"Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease","volume":"286","author":"Rao","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0380","doi-asserted-by":"crossref","first-page":"5491465","DOI":"10.1155\/2016\/5491465","article-title":"Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms","volume":"2016","author":"Li","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053028","article-title":"Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment","volume":"8","author":"Bull-Otterson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0390","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of faecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0395","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-14-40","article-title":"Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics","volume":"14","author":"Tuomisto","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0400","doi-asserted-by":"crossref","first-page":"G1018","DOI":"10.1152\/ajpgi.00245.2016","article-title":"Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota","volume":"311","author":"Bluemel","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0405","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0037-1602763","article-title":"The Human Gut Microbiome in Liver Diseases","volume":"37","author":"Davis","year":"2017","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0410","doi-asserted-by":"crossref","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0415","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00315.2013","article-title":"Colonic inflammation and secondary bile acids in alcoholic cirrhosis","volume":"306","author":"Kakiyama","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0420","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acer.12704","article-title":"Alcoholic liver disease: the gut microbiome and liver cross talk","volume":"39","author":"Hartmann","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0425","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0430","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0435","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1443-9573.2004.00157.x","article-title":"Intestinal microflora in patients with liver cirrhosis","volume":"5","author":"Zhao","year":"2004","journal-title":"Chin J Dig Dis"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0440","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0445","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1053\/j.gastro.2016.02.073","article-title":"Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?","volume":"150","author":"Betrapally","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0450","first-page":"3","article-title":"Breath hydrogen excretion in patients with alcoholic liver disease--evidence of small intestinal bacterial overgrowth","volume":"31","author":"Bode","year":"1993","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0455","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000201507","article-title":"Mucosal bacterial growth in the upper gastrointestinal tract in alcoholics (heavy drinkers)","volume":"58","author":"Hauge","year":"1997","journal-title":"Digestion"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0460","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF02282340","article-title":"Small bowel bacterial overgrowth in patients with alcoholic cirrhosis","volume":"41","author":"Casafont Morencos","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0465","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0168-8278(91)90933-3","article-title":"Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay","volume":"12","author":"Fukui","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0470","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/MEG.0b013e32834a75dc","article-title":"Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt","volume":"23","author":"Trebicka","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0475","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jhep.2013.01.038","article-title":"Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function","volume":"58","author":"Du Plessis","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0480","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","article-title":"Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease","volume":"32","author":"Parlesak","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0485","first-page":"261","article-title":"Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease","volume":"25","author":"Urbaschek","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0490","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/apt.13164","article-title":"Review article: Alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease","volume":"41","author":"Vassallo","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0495","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fphys.2012.00402","article-title":"The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease","volume":"3","author":"Hartmann","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0500","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/gutjnl-2016-312137","article-title":"Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love?","volume":"65","author":"Karlsen","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0505","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0510","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0515","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0520","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apt.13552","article-title":"The features of mucosa-associated microbiota in primary sclerosing cholangitis","volume":"43","author":"Torres","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0525","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ecco-jcc\/jju023","article-title":"The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II","volume":"9","author":"Rossen","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0530","doi-asserted-by":"crossref","first-page":"389537","DOI":"10.1155\/2013\/389537","article-title":"Role of the microbiota and antibiotics in primary sclerosing cholangitis","volume":"2013","author":"Tabibian","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111864","article-title":"Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC)","volume":"17","author":"Mattner","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0540","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0545","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/1462-2920.13401","article-title":"Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis","volume":"18","author":"Lv","year":"2016","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0550","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4254\/wjh.v8.i27.1128","article-title":"Implication of the intestinal microbiome in complications of cirrhosis","volume":"8","author":"Bhat","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0555","doi-asserted-by":"crossref","first-page":"34055","DOI":"10.1038\/srep34055","article-title":"Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0560","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0565","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hep.27819","article-title":"Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy","volume":"62","author":"Bajaj","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0570","doi-asserted-by":"crossref","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0575","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jceh.2014.12.003","article-title":"Gut microbiota: its role in hepatic encephalopathy","volume":"5","author":"Rai","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0580","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/00365528509091662","article-title":"Increased intestinal hydrolysis of urea in patients with alcoholic cirrhosis","volume":"20","author":"Hansen","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0585","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.transproceed.2016.01.077","article-title":"Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis","volume":"48","author":"Grat","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0590","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4161\/gmic.19922","article-title":"Study on the association of Helicobacter species with viral hepatitis-induced hepatocellular carcinoma","volume":"3","author":"Kruttgen","year":"2012","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0595","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000380895","article-title":"Gut Microbiota and Hepatocellular Carcinoma","volume":"2","author":"Tao","year":"2015","journal-title":"Gastrointest Tumors"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0600","doi-asserted-by":"crossref","first-page":"18933","DOI":"10.1073\/pnas.1007028107","article-title":"Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors","volume":"107","author":"Benson","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0605","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3945\/ajcn.110.010132","article-title":"Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans","volume":"94","author":"Jumpertz","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0610","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature07250","article-title":"Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits","volume":"455","author":"Brandl","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0615","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.chom.2008.05.001","article-title":"Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases","volume":"3","author":"Peterson","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0620","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1128\/AEM.67.10.4939-4942.2001","article-title":"Comparative study of bacterial groups within the human cecal and faecal microbiota","volume":"67","author":"Marteau","year":"2001","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0625","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0630","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1128\/AEM.01541-09","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0635","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0640","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.12758","article-title":"Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis","volume":"39","author":"Alisi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0645","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15403\/jgld.2014.1121.271.kby","article-title":"A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial","volume":"27","author":"Kobyliak","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0650","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1017\/S0007114517000204","article-title":"Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial","volume":"117","author":"Mofidi","year":"2017","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0655","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/MEG.0000000000000214","article-title":"Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease","volume":"26","author":"Kwak","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0660","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","article-title":"Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial","volume":"147","author":"Dhiman","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0665","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/MEG.0000000000000458","article-title":"Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study","volume":"27","author":"Han","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0670","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","article-title":"Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis","volume":"48","author":"Stadlbauer","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0675","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/liv.12172","article-title":"Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial","volume":"33","author":"Gupta","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0680","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1478-3231.2009.02020.x","article-title":"Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study","volume":"29","author":"Tandon","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0685","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/liv.12280","article-title":"VSL#3 (R) probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis","volume":"33","author":"Jayakumar","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0690","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/apt.12695","article-title":"Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis","volume":"39","author":"Bajaj","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0695","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2013.11.006","article-title":"Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial","volume":"12","author":"Lunia","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0700","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/MEG.0b013e3282efa40e","article-title":"The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study","volume":"19","author":"Lata","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003044.pub3","article-title":"Non-absorbable disaccharides versus placebo\/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"4","author":"Gluud","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0710","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","article-title":"Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study","volume":"52","author":"Malaguarnera","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0715","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0720","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/cpt.923","article-title":"Microbiota Replacement Therapies: Innovation in Gastrointestinal Care","volume":"103","author":"Khanna","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0725","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MCG.0b013e3181c87e02","article-title":"Changes in the composition of the human faecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea","volume":"44","author":"Khoruts","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0730","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy Donor Faecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0735","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Faecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.04.004_bb0740","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555919300370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555919300370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:22:32Z","timestamp":1762899752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555919300370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2589555919300370"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2019.04.004","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the gut microbiome in chronic liver disease: the clinical evidence revised","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}]}}